Evidation Health IPO

Evidation is a healthcare discovery company measures health in everyday life and enables anyone to participate in groundbreaking research and health programs.

Register for Details

For more details on financing and valuation for Evidation Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn More About Evidation Health

To invest in Evidation Health pre-IPO

Can you invest in Evidation Health pre-IPO?

Evidation Health is a privately held company and is not publicly traded, therefore investing in Evidation Health pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can learn more about Forge’s Secondary Marketplace and how to invest in private companies before their potential IPO. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

Can you sell shares of Evidation Health before it goes public?

You can seek to sell your shares in Evidation Health while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

What is the pre-IPO value of my Evidation Health shares?

To determine the value of your Evidation Health shares, create a free account to gain access to Forge’s platform. In addition to the Forge Price, Forge Markets contains pricing information for hundreds of pre-IPO companies such as Last Closed Trade Price. A Private Market Specialist will also be available to assist you with any inquiries related to your Evidation Health shares. You can also learn more about how to sell your private shares before getting started.

Is Evidation Health a publicly traded company?

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

To learn more about Evidation Health potential IPO

Will Evidation Health go IPO?

Evidation Health has not yet filed for an IPO. However, it’s important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Evidation Health’s IPO price?

The Evidation Health IPO price does not exist at this time, as Evidation Health is still a private company and has not yet conducted an IPO. To explore secondary market data and access private market pricing details and data that may be related to Evidation Health register for Forge Markets, today.

When was Evidation Health founded?

Evidation Health was founded in 2012.

What is Evidation Health funding to date?

Evidation Health has raised $625.08MM to date.

Who are Evidation Health’s major investors?

Permanente Group Trust
Omers Growth Equity
Section 32
Sanofi
Sanofi Ventures
Amv
Mckesson Ventures
Sv Health Investors
Fresco Capital
Kaiser Permanente Ventures
Rethink Impact
Revelation Partners
Undisclosed Investors
B Capital Group
Pappas Ventures
Omers Private Equity
Ge Ventures

Evidation Health Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
09/23/2024 Series E-2 $105MM $xx.xx $1.11B Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
5,671,659
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
03/22/2021 Series E $153MM $xx.xx $1B B Capital Group, Mckesson Ventures, Omers Growth Equity, Permanente Group Trust
Price per Share
$xx.xx
Shares Outstanding
8,264,416
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Mckesson Ventures, Omers Growth Equity, Permanente Group Trust
07/01/2020 Series D $45MM $xx.xx $327.81MM B Capital Group, Mckesson Ventures, Rethink Impact, Revelation Partners, Section 32, Sv Health Investors
Price per Share
$xx.xx
Shares Outstanding
6,386,328
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Mckesson Ventures, Rethink Impact, Revelation Partners, Section 32, Sv Health Investors
08/01/2018 Series C $30MM $xx.xx $217.99MM B Capital Group, Ge Ventures, Sanofi Ventures, Sv Health Investors
Price per Share
$xx.xx
Shares Outstanding
5,925,221
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Ge Ventures, Sanofi Ventures, Sv Health Investors
04/27/2017 Series B-1 $10MM $xx.xx $100.67MM B Capital Group, Ge Ventures, Sanofi
Price per Share
$xx.xx
Shares Outstanding
3,874,616
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
B Capital Group, Ge Ventures, Sanofi
10/11/2016 Series B $15.5MM $xx.xx $88.76MM Amv, B Capital Group, Fresco Capital, Ge Ventures, Pappas Ventures
Price per Share
$xx.xx
Shares Outstanding
6,826,088
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amv, B Capital Group, Fresco Capital, Ge Ventures, Pappas Ventures
01/16/2015 Series A $6.54MM $xx.xx $32.7MM Amv, Fresco Capital, Ge Ventures
Price per Share
$xx.xx
Shares Outstanding
4,901,329
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Amv, Fresco Capital, Ge Ventures
Updated on: Dec 3, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.